Table 5 The association between MAD2L1 and LUSC clinical pathological features
parameters | MAD2L1 | P value | |
|---|---|---|---|
– | + | ||
Gender | P = 0.097 | ||
male | 170 (47.8%) | 186 (52.2%) | |
female | 71 (56.3%) | 55 (43.7%) | |
Age | P = 0.100 | ||
< 60 years old | 44 (42.7%) | 59 (57.3%) | |
≥ 60 years old | 192 (51.9%) | 178 (48.1%) | |
Smoke | P = 0.973 | ||
 no | 131 (50.6%) | 128 (49.4%) | |
 Smoker < 15 years | 28 (50.0%) | 28 (50.0%) | |
 Smoker ≥15 years | 82 (49.4%) | 84 (50.6%) | |
Stage | P = 0.062 | ||
 I | 132 (56.2%) | 103 (43.8%) | |
 II | 70 (44.6%) | 87 (55.4%) | |
 III | 35 (42.7%) | 47 (57.3%) | |
 IV | 4 (57.1%) | 3 (42.9%) | |
T | P = 0.314 | ||
 I | 60 (56.1%) | 47 (43.9%) | |
 II | 131 (46.5%) | 151 (53.5%) | |
 III | 38 (54.3%) | 32 (45.7%) | |
 IV | 12 (52.2%) | 11 (47.8%) | |
N | P = 0.001 | ||
 - | 171 (55.9%) | 135 (44.1%) | |
 + | 70 (39.8%) | 106 (60.2%) | |
M | P = 0.036 | ||
 - | 188 (48.0%) | 204 (52.0%) | |
 + | 52 (60.5%) | 34 (39.5%) | |